Synthesis and biological evaluation of pentacyclic triterpenoid derivatives as potential novel antibacterial agents

Bioorg Chem. 2021 Apr:109:104692. doi: 10.1016/j.bioorg.2021.104692. Epub 2021 Feb 3.

Abstract

A series of ursolic acid (UA), oleanolic acid (OA) and 18β-glycyrrhetinic acid (GA) derivatives were synthesized by introducing a range of substituted aromatic side-chains at the C-2 position after the hydroxyl group at C-3 position was oxidized. Their antibacterial activities were evaluated in vitro against a panel of four Staphylococcus spp. The results revealed that the introduction of aromatic side-chains at the C-2 position of GA led to the discovery of potent triterpenoid derivatives for inhibition of both drug sensitive and resistant S. aureus, while the other two series derivatives of UA and OA showed no significant antibacterial activity even at high concentrations. In particular, GA derivative 33 showed good potency against all four Staphylococcus spp. (MIC = 1.25-5 μmol/L) with acceptable pharmacokinetics properties and low cytotoxicity in vitro. Molecular docking was also performed using S. aureus DNA gyrase to rationalize the observed antibacterial activity. This series of GA derivatives has strong potential for the development of a new type of triterpenoid antibacterial agent.

Keywords: 18β-glycyrrhetinic acid; Antibacterial; Gram-positive bacteria; Natural product derivatives; Pentacyclic triterpenes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology*
  • Cell Line
  • Drug Design*
  • Humans
  • Mice
  • Microbial Sensitivity Tests
  • Microglia
  • Models, Molecular
  • Molecular Structure
  • Pentacyclic Triterpenes / chemical synthesis
  • Pentacyclic Triterpenes / chemistry*
  • Pentacyclic Triterpenes / pharmacology*
  • Rats
  • Staphylococcus / drug effects

Substances

  • Anti-Bacterial Agents
  • Pentacyclic Triterpenes